Skip to main content
. 2014 Apr 29;2014(4):CD010071. doi: 10.1002/14651858.CD010071.pub3

Cervellin 2012.

Methods Randomised controlled trial: 2 blocks of 20 participants that were randomly selected by an external researcher. It is not clear how the allocation blocks were created. Participants followed for 12 months. Participants and radiologists were blinded to the intervention
Trial conducted: Department of Sports Traumatology and Arthroscopic Surgery of the Galeazzi
 Orthopaedic Institute of Milan: recruitment: 2008‐2009
Participants Participants: 40 undergoing arthroscopic ACL reconstruction
Included participants: adults requiring ACL reconstruction
Excluded participants: associated ligament damage; associated immune‐rheumatologic pathologies; chondropathies (Outerbrigde > III); pre‐existing anterior knee pain; femoropatellar pathologies and previous surgery on the same knee
Age: 
 PRT group mean (range): 22.9 years (18‐29)
 No PRT mean (range): 22.7 years (19‐27)
Gender:
PRT group: not available
 No PRT: not available
Sports activity: included patients were in "high level" of sports activity
Interventions All patients underwent ACL reconstruction with bone‐patellar tendon graft
PRT (number of participants = 20): single, intra operative intervention, 54 mL blood plus 6 mL citrate anticoagulant, 15 minutes centrifugation. Buffy coat containing PRP was centrifuged with participant's thrombin (from another venous puncture) and applied after jellified. PRP gel was applied in the patellar and tendon bone plug harvest site and fixed with peritenon suture
PRT preparation: kit: Gravitional Platelet Separation (GPS II). Addiction of CaCl2 and autologous thrombin
Quantification of platelet concentrates after preparation: not assessed
No PRT (number of participants = 20): no platelet‐rich therapy controls
Co‐Interventions: same rehabilitation protocol
Outcomes VISA
VAS
MRI (assessment of new bone formation in the graft site; gap filling > 70% considered as satisfactory)
Other quality issues Sample size: the authors did not calculate the sample size
Validation of PRT: PRT concentration or its validation was not reported
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation Unclear risk Not reported
Allocation concealment Unclear risk Not reported
Blinding 
 All outcomes Unclear risk Participants and radiologists were blinded to the intervention
Incomplete outcome data addressed 
 All outcomes Low risk No missing outcome data
Free of selective reporting Unclear risk The study protocol was not available. Relevant outcomes were reported
Free of other bias Low risk The study appears to be free of other sources of bias